Discontinued — last reported Q4 '22
International Flavors & Fragrances Health & Biosciences — Acquisitions remained flat by 0.0% to $11.25M in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 81.6%, from $61.00M to $11.25M.
Higher spending indicates an aggressive growth strategy, while lower spending suggests a focus on organic growth or capital preservation.
This metric quantifies the capital deployed for the purchase of businesses or assets to expand the Health & Biosciences...
Widely used across all sectors to track inorganic growth and capital allocation efficiency.
iff_segment_health_biosciences_acquisitions| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|
| Value | $403.00M | $61.00M | $11.25M | $11.25M | $11.25M | $11.25M |
| QoQ Change | — | -84.9% | -81.6% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | -97.2% | — | -81.6% |